Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma
NCT00003280
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
240
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma
Interventions
BIOLOGICAL:
rituximab
Sponsor
Swiss Cancer Institute